This report provides a comprehensive analysis of the global liposome service market, focusing on the preparation, optimization, and encapsulation of liposomes for pharmaceutical, life science, and cosmetic applications. It examines key market dynamics, including the rising demand for highly customized delivery solutions for drugs, genes, and vaccines. By evaluating regional trends, competitive landscapes, and technological advancements, the study offers detailed forecasts and segmentation by service type and application to identify emerging growth opportunities through 2032.

Market Overview

The global Liposome Service market size is predicted to grow from US$ 1785 million in 2025 to US$ 2476 million in 2032, with an expected compound annual growth rate (CAGR) of 4.9% from 2026 to 2032.

Definition: Liposome services mainly refer to the preparation, optimization, and encapsulation of liposomes to provide delivery and packaging services for drugs, genes, vaccines, and other substances.

Key Trend: Since each application scenario may require different liposomes, the ability to provide highly customized liposome services is expected to be an important future trend.

Report Scope and Methodology

LPI (LP Information)' newest research report, the “Liposome Service Industry Forecast,” reviews total world Liposome Service sales in 2025 and provides a comprehensive analysis of projected Liposome Service sales from 2026 through 2032. The report provides a detailed analysis in US$ millions of the world Liposome Service industry, with sales broken down by region, market sector, and sub-sector.

This Insight Report provides a comprehensive analysis of the global Liposome Service landscape and highlights key trends related to:

• Product segmentation
• Company formation
• Revenue and market share
• Latest developments
• M&A activity

Furthermore, the report analyzes the strategies of leading global companies, focusing on:

• Liposome Service portfolios and capabilities
• Market entry strategies
• Market positions
• Geographic footprints

To provide a nuanced view of the current state and future trajectory of the global Liposome Service market, the study evaluates key market trends, drivers, and affecting factors. The forecast is broken down by Type, Application, Geography, and Market Size to highlight emerging pockets of opportunity. The methodology is transparent, based on hundreds of bottom-up qualitative and quantitative market inputs.

This report presents a comprehensive overview, market shares, and growth opportunities of the Liposome Service market by product type, application, key players, and key regions and countries.

Market Segmentation

By Type

• Liposome Development Services
• Liposome Customization Service
• Liposome Encapsulation Services
• Others

By Application

• Pharmaceutical
• Life Sciences
• Cosmetics and Skin Care Industrial
• Others

By Region

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

Competitive Landscape

The following companies have been profiled based on inputs gathered from primary experts and analysis of the companies' coverage, product portfolios, and market penetration:

• Acuitas Therapeutics
• CD Bioparticles
• Corden Pharma
• Creative Biolabs
• Creative Biostruct
• Encapsula NanoSciences
• Evonik
• Exelead
• FormuMax Scientific
• FUJIFILM Pharmaceuticals USA
• GMPriority Pharma
• Lipoid
• LIPOSOMA
• Merck KGaA
• Nippon Fine Chemical
• PlantaCorp
• Polymun

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Liposome Service Market Size (2021-2032)

    • 2.1.2 Liposome Service Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Liposome Service by Country/Region (2021, 2025 & 2032)

  • 2.2 Liposome Service Segment by Type

    • 2.2.1 Liposome Development Services

    • 2.2.2 Liposome Customization Service

    • 2.2.3 Liposome Encapsulation Services

    • 2.2.4 Others

    • 2.2.5 Liposome Service Market Size by Type

      • 2.2.5.1 Liposome Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.5.2 Global Liposome Service Market Size Market Share by Type (2021-2026)

  • 2.3 Liposome Service Segment by Application

    • 2.3.1 Pharmaceutical

    • 2.3.2 Life Sciences

    • 2.3.3 Cosmetics and Skin Care Industrial

    • 2.3.4 Others

    • 2.3.5 Liposome Service Market Size by Application

      • 2.3.5.1 Liposome Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.5.2 Global Liposome Service Market Size Market Share by Application (2021-2026)

• 3 Liposome Service Market Size by Player

  • 3.1 Liposome Service Market Size Market Share by Player

    • 3.1.1 Global Liposome Service Revenue by Player (2021-2026)

    • 3.1.2 Global Liposome Service Revenue Market Share by Player (2021-2026)

  • 3.2 Global Liposome Service Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Liposome Service by Region

  • 4.1 Liposome Service Market Size by Region (2021-2026)

  • 4.2 Global Liposome Service Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Liposome Service Market Size Growth (2021-2026)

  • 4.4 APAC Liposome Service Market Size Growth (2021-2026)

  • 4.5 Europe Liposome Service Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Liposome Service Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Liposome Service Market Size by Country (2021-2026)

  • 5.2 Americas Liposome Service Market Size by Type (2021-2026)

  • 5.3 Americas Liposome Service Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Liposome Service Market Size by Region (2021-2026)

  • 6.2 APAC Liposome Service Market Size by Type (2021-2026)

  • 6.3 APAC Liposome Service Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Liposome Service Market Size by Country (2021-2026)

  • 7.2 Europe Liposome Service Market Size by Type (2021-2026)

  • 7.3 Europe Liposome Service Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Liposome Service by Region (2021-2026)

  • 8.2 Middle East & Africa Liposome Service Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Liposome Service Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Liposome Service Market Forecast

  • 10.1 Global Liposome Service Forecast by Region (2027-2032)

    • 10.1.1 Global Liposome Service Forecast by Region (2027-2032)

    • 10.1.2 Americas Liposome Service Forecast

    • 10.1.3 APAC Liposome Service Forecast

    • 10.1.4 Europe Liposome Service Forecast

    • 10.1.5 Middle East & Africa Liposome Service Forecast

  • 10.2 Americas Liposome Service Forecast by Country (2027-2032)

    • 10.2.1 United States Market Liposome Service Forecast

    • 10.2.2 Canada Market Liposome Service Forecast

    • 10.2.3 Mexico Market Liposome Service Forecast

    • 10.2.4 Brazil Market Liposome Service Forecast

  • 10.3 APAC Liposome Service Forecast by Region (2027-2032)

    • 10.3.1 China Liposome Service Market Forecast

    • 10.3.2 Japan Market Liposome Service Forecast

    • 10.3.3 Korea Market Liposome Service Forecast

    • 10.3.4 Southeast Asia Market Liposome Service Forecast

    • 10.3.5 India Market Liposome Service Forecast

    • 10.3.6 Australia Market Liposome Service Forecast

  • 10.4 Europe Liposome Service Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Liposome Service Forecast

    • 10.4.2 France Market Liposome Service Forecast

    • 10.4.3 UK Market Liposome Service Forecast

    • 10.4.4 Italy Market Liposome Service Forecast

    • 10.4.5 Russia Market Liposome Service Forecast

  • 10.5 Middle East & Africa Liposome Service Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Liposome Service Forecast

    • 10.5.2 South Africa Market Liposome Service Forecast

    • 10.5.3 Israel Market Liposome Service Forecast

    • 10.5.4 Turkey Market Liposome Service Forecast

  • 10.6 Global Liposome Service Forecast by Type (2027-2032)

  • 10.7 Global Liposome Service Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Liposome Service Forecast

• 11 Key Players Analysis

  • 11.1 Acuitas Therapeutics

    • 11.1.1 Acuitas Therapeutics Company Information

    • 11.1.2 Acuitas Therapeutics Liposome Service Product Offered

    • 11.1.3 Acuitas Therapeutics Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Acuitas Therapeutics Main Business Overview

    • 11.1.5 Acuitas Therapeutics Latest Developments

  • 11.2 CD Bioparticles

    • 11.2.1 CD Bioparticles Company Information

    • 11.2.2 CD Bioparticles Liposome Service Product Offered

    • 11.2.3 CD Bioparticles Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 CD Bioparticles Main Business Overview

    • 11.2.5 CD Bioparticles Latest Developments

  • 11.3 Corden Pharma

    • 11.3.1 Corden Pharma Company Information

    • 11.3.2 Corden Pharma Liposome Service Product Offered

    • 11.3.3 Corden Pharma Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 Corden Pharma Main Business Overview

    • 11.3.5 Corden Pharma Latest Developments

  • 11.4 Creative Biolabs

    • 11.4.1 Creative Biolabs Company Information

    • 11.4.2 Creative Biolabs Liposome Service Product Offered

    • 11.4.3 Creative Biolabs Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Creative Biolabs Main Business Overview

    • 11.4.5 Creative Biolabs Latest Developments

  • 11.5 Creative Biostruct

    • 11.5.1 Creative Biostruct Company Information

    • 11.5.2 Creative Biostruct Liposome Service Product Offered

    • 11.5.3 Creative Biostruct Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 Creative Biostruct Main Business Overview

    • 11.5.5 Creative Biostruct Latest Developments

  • 11.6 Encapsula NanoSciences

    • 11.6.1 Encapsula NanoSciences Company Information

    • 11.6.2 Encapsula NanoSciences Liposome Service Product Offered

    • 11.6.3 Encapsula NanoSciences Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 Encapsula NanoSciences Main Business Overview

    • 11.6.5 Encapsula NanoSciences Latest Developments

  • 11.7 Evonik

    • 11.7.1 Evonik Company Information

    • 11.7.2 Evonik Liposome Service Product Offered

    • 11.7.3 Evonik Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Evonik Main Business Overview

    • 11.7.5 Evonik Latest Developments

  • 11.8 Exelead

    • 11.8.1 Exelead Company Information

    • 11.8.2 Exelead Liposome Service Product Offered

    • 11.8.3 Exelead Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 Exelead Main Business Overview

    • 11.8.5 Exelead Latest Developments

  • 11.9 FormuMax Scientific

    • 11.9.1 FormuMax Scientific Company Information

    • 11.9.2 FormuMax Scientific Liposome Service Product Offered

    • 11.9.3 FormuMax Scientific Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 FormuMax Scientific Main Business Overview

    • 11.9.5 FormuMax Scientific Latest Developments

  • 11.10 FUJIFILM Pharmaceuticals USA

    • 11.10.1 FUJIFILM Pharmaceuticals USA Company Information

    • 11.10.2 FUJIFILM Pharmaceuticals USA Liposome Service Product Offered

    • 11.10.3 FUJIFILM Pharmaceuticals USA Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 FUJIFILM Pharmaceuticals USA Main Business Overview

    • 11.10.5 FUJIFILM Pharmaceuticals USA Latest Developments

  • 11.11 GMPriority Pharma

    • 11.11.1 GMPriority Pharma Company Information

    • 11.11.2 GMPriority Pharma Liposome Service Product Offered

    • 11.11.3 GMPriority Pharma Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 GMPriority Pharma Main Business Overview

    • 11.11.5 GMPriority Pharma Latest Developments

  • 11.12 Lipoid

    • 11.12.1 Lipoid Company Information

    • 11.12.2 Lipoid Liposome Service Product Offered

    • 11.12.3 Lipoid Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Lipoid Main Business Overview

    • 11.12.5 Lipoid Latest Developments

  • 11.13 LIPOSOMA

    • 11.13.1 LIPOSOMA Company Information

    • 11.13.2 LIPOSOMA Liposome Service Product Offered

    • 11.13.3 LIPOSOMA Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 LIPOSOMA Main Business Overview

    • 11.13.5 LIPOSOMA Latest Developments

  • 11.14 Merck KGaA

    • 11.14.1 Merck KGaA Company Information

    • 11.14.2 Merck KGaA Liposome Service Product Offered

    • 11.14.3 Merck KGaA Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Merck KGaA Main Business Overview

    • 11.14.5 Merck KGaA Latest Developments

  • 11.15 Nippon Fine Chemical

    • 11.15.1 Nippon Fine Chemical Company Information

    • 11.15.2 Nippon Fine Chemical Liposome Service Product Offered

    • 11.15.3 Nippon Fine Chemical Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Nippon Fine Chemical Main Business Overview

    • 11.15.5 Nippon Fine Chemical Latest Developments

  • 11.16 PlantaCorp

    • 11.16.1 PlantaCorp Company Information

    • 11.16.2 PlantaCorp Liposome Service Product Offered

    • 11.16.3 PlantaCorp Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.16.4 PlantaCorp Main Business Overview

    • 11.16.5 PlantaCorp Latest Developments

  • 11.17 Polymun

    • 11.17.1 Polymun Company Information

    • 11.17.2 Polymun Liposome Service Product Offered

    • 11.17.3 Polymun Liposome Service Revenue, Gross Margin and Market Share (2021-2026)

    • 11.17.4 Polymun Main Business Overview

    • 11.17.5 Polymun Latest Developments

• 12 Research Findings and Conclusion